Christina Kabbash, MD
Foot and Ankle Surgery · Naples, FLNPI 1306954755
Payments from drug & device makers
Across 72 payments — averaging $510.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Synthes USA Products LLC$19K
- Synthes GmbH$16K
- Arthrex$653
- Stryker$79
- Sunovion Pharmaceuticals Inc.$76
- Zimmer Biomet$52
- plus $334 from 14 others
What the payments were for
- Consulting fees$18,15049%
- Speaking & faculty fees$8,50923%
- Travel & lodging$8,88824%
- Food & beverage$1,2033%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Synthes USA Products LLC | 10 | $19,144 |
| Synthes GmbH | 25 | $16,412 |
| Arthrex | 14 | $653 |
| Stryker | 1 | $79 |
| Sunovion Pharmaceuticals Inc. | 4 | $76 |
| Zimmer Biomet | 2 | $52 |
| DJO, LLC | 2 | $46 |
| ERMI LLC | 1 | $45 |
| Smith+Nephew | 2 | $31 |
| Crossroads Extremity Systems, LLC | 1 | $26 |
| Solventum Corporation | 1 | $26 |
| Orthofix Medical, Inc. | 1 | $22 |
| Tersera Therapeutics LLC | 1 | $20 |
| Pacira Therapeutics, Inc. | 1 | $19 |
| Baudax Bio Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Resmed Corp | 1 | $17 |
| Checkpoint Surgical, Inc | 1 | $16 |
| Fidia Pharma USA Inc. | 1 | $15 |
| Heraeus Medical, LLC. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HEADLESS COMPRESSION SCREWS$12,100
- NA$6,050
- VA-LCP PLATES & SCREWS$965
- ARTHREX$146
How this compares
$36,750 in reported general payments places this provider in the 90th percentile of 850 foot and ankle surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 16 | $308 |
| Gabapentin | 24 | $230 |
| Doxycycline Hyclate | 26 | $228 |
| Tramadol Hcl | 99 | $211 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $80 |
| Meloxicam | 20 | $49 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Naples
- Cody TogherNaples$60K
- Richard DeaslaNaples$47K
- Thomas SangiovanniCoral Gables$2.1M
- Shayne JensenPanama City$1.3M
- Thomas RoukisOrlando$1.1M
- Craig BreslauerStuart$971K
- Bradley LammWest Palm Beach$938K
- Amber ShaneOrlando$830K
- Jonathan BlumKissimmee$814K
- Riquel GonzalezHialeah$612K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.